T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ways they affect the body—both helpful and harmful—beyond reducing weight.
New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...
Hosted on MSN25d
Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kindWeight-loss drugs like Ozempic may ... use disorders (both an 11% lower risk), as well as having a 12% lower risk of experiencing bacterial infections. These effects may somehow be linked to both the ...
Hosted on MSN20d
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risksThe Food and Drug Administration’s approval of Ozempic in 2021 for ... On Jan. 20, 2025, my team published a study of more than 2.4 million people that evaluated the risks and benefits of GLP-1 drugs ...
In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...
The newest weight-loss drugs, Wegovy and Zepbound ... obesity produces good health benefits across the board beyond just reduction in weight. But there are also risks, and we hope these findings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback